
Intra-arterial clot-busting medicines don’t help after stroke thrombectomy
UC expert featured in TCTMD article
The University of Cincinnati's Pooja Khatri, MD, spoke with TCTMD about two recent trials that found administering clot-busting medications after endovascular thrombectomy does not significantly improve outcomes for patients with acute ischemic stroke. Thrombectomy is a minimally invasive stroke procedure that uses a catheter to remove a blood clot from a blood vessel in the brain to restore blood flow.
These results come after a previous trial found a large and significant benefit in administering a medication called alteplase after successful thrombectomy.
Khatri, professor, vice chair of research and division chief in the Department of Neurology and Rehabilitation Medicine at UC's College of Medicine, associate director of the UC Gardner Neuroscience Institute and codirector of NIH StrokeNet’s National Coordinating Center, who was not involved in any of the trials, said the original trial was a smaller study that ended prematurely and included patients with a wider range of results after thrombectomy.
These newer data “are promising in terms of a therapeutic strategy with thrombolysis to attack distal visualized clots and maybe impaired microcirculatory reperfusion, or the no-reflow phenomenon as we like to call it,” she said, adding, however, that “I’m disappointed that the potential effect isn’t bigger.”
Featured photo at top of UC Health's mobile stroke unit courtesy of UC Health.
Remember how to identify a stroke
Because of the quick onset of stroke, it is important to know the FAST mnemonic device that details the most common signs of stroke and how to respond:
- F: Facial drooping
- A: Arm or leg drop, or weakness in the arm or leg
- S: Speech issues, such as slurred speech or an inability to get your words out
- T: Time is of the essence; call 911 immediately
Related Stories
CureToday: UC enrolling patients for glioblastoma trial
March 29, 2022
CureToday highlighted the University of Cincinnati's new glioblastoma immunotherapy trial in a recent article.
55KRC: UC researchers examine role of stress in Parkinson's disease
March 8, 2022
University of Cincinnati researchers Kim Seroogy, Teresa Reyes and James Herman were featured on 55KRC's Simply Medicine program to discuss their research into the role of stress in Parkinson's disease.
Could daydreaming actually be healthy for your brain?
July 11, 2024

The University of Cincinnati's Rhonna Shatz and Cincinnati Children's Stephen Becker joined WVXU's Cincinnati Edition to discuss research on how daydreaming can affect the brain of children and adults.